Virtu Financial LLC Bio Xcel Therapeutics, Inc. Transaction History

Virtu Financial LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$1.14 - $2.97 $49,416 - $128,743	43,348 Added 309.85%	57,338 $73,000
Q1 2024 May 20, 2024	SELL	$1.95 - $4.04 $88,771 - $183,916	-45,524 Reduced 76.49%	13,990 $39,000
Q4 2023 Feb 26, 2024	BUY	$2.32 - $5.51 $138,072 - $327,922	59,514 New	59,514 $176,000
Q1 2022 May 17, 2022	SELL	$15.0 - $22.83 $184,260 - $280,443	-12,284 Closed	0 $0
Q4 2021 Feb 17, 2022	BUY	$20.12 - $35.09 $247,154 - $431,045	12,284 New	12,284 $250,000

3.14M

22.2K

40.2K

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $12.6M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.